Despite advancements, several challenges remain in cancer toxicology. These include the complexity of cancer mechanisms, inter-individual variability in response to carcinogens, and the long latency period between exposure and cancer development. Addressing these challenges requires ongoing research and the integration of advanced technologies such as genomics and bioinformatics.
